Literature DB >> 28315707

Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.

Belén Borrego1, Esther Blanco2, Miguel Rodríguez Pulido3, Francisco Mateos4, Gema Lorenzo5, Sabrina Cardillo6, Eliana Smitsaart7, Francisco Sobrino8, Margarita Sáiz9.   

Abstract

Foot-and-mouth disease virus (FMDV) is the causative agent of a highly contagious disease and a major concern in animal health worldwide. We have previously reported the use of RNA transcripts mimicking structural domains in the non-coding regions of the FMDV RNA as potent type-I interferon (IFN) inducers showing antiviral effect in vivo, as well as their immunomodulatory properties in combination with an FMD vaccine in mice. Here, we describe the enhancing effect of RNA delivery on the immunogenicity and protection induced by a suboptimal dose of a conventional FMD vaccine in pigs. Animals receiving the RNA developed earlier and higher levels of neutralizing antibodies against homologous and heterologous isolates, compared to those immunized with the vaccine alone, and had higher anti-FMDV titers at late times post-vaccination. RNA delivery also induced higher specific T-cell response and protection levels against FMDV challenge. Peripheral blood mononuclear cells from pigs inoculated with RNA and the vaccine had a higher IFN-γ specific response than those from pigs receiving the vaccine alone. When challenged with FMDV, all three animals immunized with the conventional vaccine developed antibodies to the non-structural viral proteins 3ABC and two of them developed severe signs of disease. In the group receiving the vaccine together with the RNA, two pigs were fully protected while one showed delayed and mild signs of disease. Our results support the immunomodulatory effect of these RNA molecules in natural hosts and suggest their potential use for improvement of FMD vaccines strategies.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FMD vaccines; Foot-and-mouth disease virus; Immunomodulatory molecules; Non-coding RNA; Vaccine adjuvants

Mesh:

Substances:

Year:  2017        PMID: 28315707     DOI: 10.1016/j.antiviral.2017.03.009

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  9 in total

1.  Formulation and Delivery Technologies for mRNA Vaccines.

Authors:  Chunxi Zeng; Chengxiang Zhang; Patrick G Walker; Yizhou Dong
Journal:  Curr Top Microbiol Immunol       Date:  2020-06-02       Impact factor: 4.291

2.  Ribavirin as a curative and prophylactic agent against foot and mouth disease virus infection in C57BL/6 suckling and adult mice model.

Authors:  Patel Nikunjkumar; Ramasamy Periyasamy Tamil Selvan; Veerakyathappa Bhanuprakash
Journal:  Virusdisease       Date:  2021-10-20

3.  The C3d-fused foot-and-mouth disease vaccine platform overcomes maternally-derived antibody interference by inducing a potent adaptive immunity.

Authors:  Min Ja Lee; Hyun Mi Kim; Sehee Shin; Hyundong Jo; So Hui Park; Su-Mi Kim; Jong-Hyeon Park
Journal:  NPJ Vaccines       Date:  2022-06-28       Impact factor: 9.399

Review 4.  Molecular Mechanisms of Foot-and-Mouth Disease Virus Targeting the Host Antiviral Response.

Authors:  Miguel Rodríguez Pulido; Margarita Sáiz
Journal:  Front Cell Infect Microbiol       Date:  2017-06-13       Impact factor: 5.293

Review 5.  Type I Interferon Induced and Antagonized by Foot-and-Mouth Disease Virus.

Authors:  Xiao-Xia Ma; Li-Na Ma; Qiu-Yan Chang; Peng Ma; Lin-Jie Li; Yue-Ying Wang; Zhong-Ren Ma; Xin Cao
Journal:  Front Microbiol       Date:  2018-08-13       Impact factor: 5.640

6.  Innate immune sensor LGP2 is cleaved by the Leader protease of foot-and-mouth disease virus.

Authors:  Miguel Rodríguez Pulido; María Teresa Sánchez-Aparicio; Encarnación Martínez-Salas; Adolfo García-Sastre; Francisco Sobrino; Margarita Sáiz
Journal:  PLoS Pathog       Date:  2018-06-29       Impact factor: 6.823

Review 7.  Foot-and-Mouth Disease Virus: Immunobiology, Advances in Vaccines and Vaccination Strategies Addressing Vaccine Failures-An Indian Perspective.

Authors:  Raj Kumar Singh; Gaurav Kumar Sharma; Sonalika Mahajan; Kuldeep Dhama; Suresh H Basagoudanavar; Madhusudan Hosamani; B P Sreenivasa; Wanpen Chaicumpa; Vivek Kumar Gupta; Aniket Sanyal
Journal:  Vaccines (Basel)       Date:  2019-08-16

Review 8.  Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review.

Authors:  Ehsan Raoufi; Bahar Bahramimeimandi; M Salehi-Shadkami; Patcharida Chaosri; M R Mozafari
Journal:  Biomedicines       Date:  2021-05-06

9.  Swine T-Cells and Specific Antibodies Evoked by Peptide Dendrimers Displaying Different FMDV T-Cell Epitopes.

Authors:  Patricia de León; Rodrigo Cañas-Arranz; Sira Defaus; Elisa Torres; Mar Forner; María J Bustos; Concepción Revilla; Javier Dominguez; David Andreu; Esther Blanco; Francisco Sobrino
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.